rs129967

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004380.3(CREBBP):​c.4280+42C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0477 in 1,612,982 control chromosomes in the GnomAD database, including 9,585 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 4131 hom., cov: 33)
Exomes 𝑓: 0.038 ( 5454 hom. )

Consequence

CREBBP
NM_004380.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.192

Publications

6 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 16-3739536-G-A is Benign according to our data. Variant chr16-3739536-G-A is described in ClinVar as [Benign]. Clinvar id is 1242603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CREBBPNM_004380.3 linkc.4280+42C>T intron_variant Intron 25 of 30 ENST00000262367.10 NP_004371.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CREBBPENST00000262367.10 linkc.4280+42C>T intron_variant Intron 25 of 30 1 NM_004380.3 ENSP00000262367.5 Q92793-1

Frequencies

GnomAD3 genomes
AF:
0.145
AC:
22038
AN:
152006
Hom.:
4113
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.428
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0728
Gnomad ASJ
AF:
0.0850
Gnomad EAS
AF:
0.205
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.00340
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0129
Gnomad OTH
AF:
0.126
GnomAD2 exomes
AF:
0.0759
AC:
19019
AN:
250528
AF XY:
0.0711
show subpopulations
Gnomad AFR exome
AF:
0.448
Gnomad AMR exome
AF:
0.0369
Gnomad ASJ exome
AF:
0.0752
Gnomad EAS exome
AF:
0.220
Gnomad FIN exome
AF:
0.00301
Gnomad NFE exome
AF:
0.0143
Gnomad OTH exome
AF:
0.0513
GnomAD4 exome
AF:
0.0376
AC:
54889
AN:
1460858
Hom.:
5454
Cov.:
31
AF XY:
0.0388
AC XY:
28225
AN XY:
726724
show subpopulations
African (AFR)
AF:
0.450
AC:
15046
AN:
33432
American (AMR)
AF:
0.0417
AC:
1862
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.0780
AC:
2038
AN:
26124
East Asian (EAS)
AF:
0.193
AC:
7640
AN:
39662
South Asian (SAS)
AF:
0.121
AC:
10411
AN:
86172
European-Finnish (FIN)
AF:
0.00414
AC:
221
AN:
53396
Middle Eastern (MID)
AF:
0.0789
AC:
446
AN:
5654
European-Non Finnish (NFE)
AF:
0.0118
AC:
13090
AN:
1111406
Other (OTH)
AF:
0.0685
AC:
4135
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2670
5340
8009
10679
13349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.145
AC:
22100
AN:
152124
Hom.:
4131
Cov.:
33
AF XY:
0.142
AC XY:
10584
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.428
AC:
17743
AN:
41438
American (AMR)
AF:
0.0727
AC:
1111
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0850
AC:
295
AN:
3472
East Asian (EAS)
AF:
0.205
AC:
1062
AN:
5180
South Asian (SAS)
AF:
0.130
AC:
628
AN:
4814
European-Finnish (FIN)
AF:
0.00340
AC:
36
AN:
10598
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0129
AC:
875
AN:
68024
Other (OTH)
AF:
0.125
AC:
264
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
701
1403
2104
2806
3507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0640
Hom.:
1929
Bravo
AF:
0.165
Asia WGS
AF:
0.183
AC:
638
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
1.3
DANN
Benign
0.60
PhyloP100
0.19
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs129967; hg19: chr16-3789537; COSMIC: COSV52117696; COSMIC: COSV52117696; API